Zhenqiang Zhang - Search Results

Year	Number of Results
2006	1
2007	1
2012	1
2013	1
2016	3
2017	1
2018	1
2019	9
2020	17
2021	13
2022	28
2023	28
2024	15

1

Hederagenin improves Alzheimer's disease through PPARα/TFEB-mediated autophagy.

Xie ZS, Zhao JP, Wu LM, Chu S, Cui ZH, Sun YR, Wang H, Ma HF, Ma DR, Wang P, Zhang XW, Zhang ZQ. Xie ZS, et al. Phytomedicine. 2023 Apr;112:154711. doi: 10.1016/j.phymed.2023.154711. Epub 2023 Feb 9. Phytomedicine. 2023. PMID: 36809694

2

Inhibition of ferroptosis through regulating neuronal calcium homeostasis: An emerging therapeutic target for Alzheimer's disease.

Sun 孙意冉 Y, Yan C, He L, Xiang S, Wang P, Li Z, Chen Y, Zhao J, Yuan Y, Wang W, Zhang X, Su P, Su Y, Ma J, Xu J, Peng Q, Ma H, Xie Z, Zhang Z. Sun 孙意冉 Y, et al. Among authors: zhang z. Ageing Res Rev. 2023 Jun;87:101899. doi: 10.1016/j.arr.2023.101899. Epub 2023 Mar 4. Ageing Res Rev. 2023. PMID: 36871781 Review.

3

Peptide-drug co-assembling: A potent armament against cancer.

Wu C, Wang M, Sun J, Jia Y, Zhu X, Liu G, Zhu Y, Guan Y, Zhang Z, Pang X. Wu C, et al. Among authors: zhang z. Theranostics. 2023 Sep 25;13(15):5322-5347. doi: 10.7150/thno.87356. eCollection 2023. Theranostics. 2023. PMID: 37908727 Free PMC article. Review.

4

Ion Pair Catalyst - Pentanidinium.

Qin Y, Zhang Z, Ye X, Tan CH. Qin Y, et al. Among authors: zhang z. Chem Rec. 2023 Jul;23(7):e202200304. doi: 10.1002/tcr.202200304. Epub 2023 Feb 10. Chem Rec. 2023. PMID: 36762723 Review.

5

Biological and therapeutic role of LSD1 in Alzheimer's diseases.

Li Y, Zhao Y, Li X, Zhai L, Zheng H, Yan Y, Fu Q, Ma J, Fu H, Zhang Z, Li Z. Li Y, et al. Among authors: zhang z. Front Pharmacol. 2022 Oct 25;13:1020556. doi: 10.3389/fphar.2022.1020556. eCollection 2022. Front Pharmacol. 2022. PMID: 36386192 Free PMC article. Review.

6

Zexie Tang targeting FKBP38/mTOR/SREBPs pathway improves hyperlipidemia.

Xie Z, Li EW, Gao G, Du Y, Wang M, Wang H, Wang P, Qiao Y, Su Y, Xu J, Zhang X, Zhang Z. Xie Z, et al. Among authors: zhang z. J Ethnopharmacol. 2022 May 23;290:115101. doi: 10.1016/j.jep.2022.115101. Epub 2022 Feb 11. J Ethnopharmacol. 2022. PMID: 35151834

7

DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson's Disease Rat Model.

Zhang L, Li C, Zhang Z, Zhang Z, Jin QQ, Li L, Hölscher C. Zhang L, et al. Among authors: zhang z. Parkinsons Dis. 2022 Nov 14;2022:1428817. doi: 10.1155/2022/1428817. eCollection 2022. Parkinsons Dis. 2022. PMID: 36419409 Free PMC article.

8

Integrated bioinformatic analysis and experimental validation for exploring the key molecular of brain inflammaging.

Du Z, Wang Y, Yang L, Zhang T, Jiang Y, Zhang Z. Du Z, et al. Among authors: zhang z. Front Immunol. 2023 Jul 10;14:1213351. doi: 10.3389/fimmu.2023.1213351. eCollection 2023. Front Immunol. 2023. PMID: 37492566 Free PMC article.

9

Non-coding RNAs in Ischemic Stroke: Roles in the Neuroinflammation and Cell Death.

Lu M, Dong X, Zhang Z, Li W, Khoshnam SE. Lu M, et al. Among authors: zhang z. Neurotox Res. 2020 Oct;38(3):564-578. doi: 10.1007/s12640-020-00236-7. Epub 2020 Jun 23. Neurotox Res. 2020. PMID: 32578041 Review.

10

A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson's Disease.

Zhang Z, Shi M, Li Z, Ling Y, Zhai L, Yuan Y, Ma H, Hao L, Li Z, Zhang Z, Hölscher C. Zhang Z, et al. Parkinsons Dis. 2023 Sep 25;2023:7427136. doi: 10.1155/2023/7427136. eCollection 2023. Parkinsons Dis. 2023. PMID: 37791037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year